Pay in 4 interest-free payments of $24.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
FOY-251 inhibits the proteolytic activity of prostasin
InChiKey: MULNCJWAVSDEKJ-UHFFFAOYSA-N
Metastatic Castration-Resistant Prostate Cancer: Critical Review of MDV-3100
52)/b47-37+/t32-
CAS Number: 90332-63-1
Dapagliflozin chin gallate FOY-251 inhibits the proteolytic activityDapagliflozin, also known as BMS 512148, is a drug used to treat type 2 diabetes approved in 2012 by FDA. Dapagliflozin inhibits subtype 2 of the sodium glucose transport proteins (SGLT2) which are responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter mechanism causes blood glucose to be eliminated through the urine. In clinical trials, dapagliflozin lowered HbA1c by 0. 6 versus placebo percentage points